[Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]. / Kommentar der Deutschen Atemwegsliga (DAL) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) zur Mitteilung der US amerikanischen Food and Drug Administration (FDA) vom 18. 2. 2010 über die Anwendung lang wirksamer Beta-2-Adrenergika (LABAs) in der Behandlung von Asthmapatienten.
Pneumologie
; 64(6): 333-5, 2010 Jun.
Article
in De
| MEDLINE
| ID: mdl-20533125
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Societies, Medical
/
United States Food and Drug Administration
/
Bronchodilator Agents
/
Pulmonary Medicine
/
Adrenergic beta-Agonists
/
Albuterol
/
Ethanolamines
Type of study:
Guideline
/
Systematic_reviews
Limits:
Adult
/
Child
/
Humans
Country/Region as subject:
America do norte
/
Europa
Language:
De
Journal:
Pneumologie
Year:
2010
Document type:
Article
Country of publication:
Germany